Cancer, biotechs fight against it | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Cancer, biotechs fight against it

An SI Board Since August 1998

Posts	SubjectMarks	Bans
10	0	0

Emcee: Jongmans	Type: Unmoderated

Introduction Compact

SERIES OF INTERESTING ARTICLES ON THIS SUBJECT IN THE BOSTON GLOBE

boston.com

etc.

Martin

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
10	James The limitations of the mice model are presented in Science Vol. 278, Nov	seminole	-	8/17/1998
9	I have posted two separate links on the TSNG thread. Go there and let us know w	Longball	-	8/11/1998
8	Go to the tseng thread, TSNG. Subject 1657 I used to own some TSNG, sold befo	Mike McFarland	-	8/10/1998
7	Prevention is certainly a better answer, but we are years and probably decade	Mike K	-	8/10/1998
6	Mice - Schmice Cell Pathways is finishing phase III human trials. Anyone still	Longball	-	8/10/1998
5	Thanks for the reply. Why SUGN more so than ENMD? Regards, Jim	James Y.	-	8/9/1998
4	Jim; It's my understanding, that animal models (particularly mice) can pro	Mike K	-	8/8/1998
3	Animal models? IMGN has a treatment that eradicates colorectal tumors in mice.	James Y.	-	8/8/1998
2	Here's a related article. msnbc.com	Longball	-	8/5/1998
1	Thanks for the link! Been following SUGN, ENMD, LGND, NERX! Mike	Mike K	-	8/3/1998

Go to reply# or date (mm/dd/yy):